A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer

Overview of attention for article published in The AAPS Journal, June 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 113 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 53 publications that cite this research output.

53

The most recent citing publications are shown below. View all 53 publications that cite this research output on Dimensions.

Predicting efficacy assessment of combined treatment of radiotherapy and nivolumab for NSCLC patients through virtual clinical trials using QSP modeling

Article in Journal of Pharmacokinetics and Pharmacodynamics (March 2024)

From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling

Preprint in arXiv (March 2024)

Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer

Article in Pharmaceuticals (February 2024)